sPLA2 inhibition to decrease enzyme release after PCI trial (SPIDER-PCI).
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2012
At a glance
- Drugs Varespladib (Primary)
- Indications Myocardial infarction; Myocardial reperfusion injury
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SPIDER-PCI
- 07 Jun 2017 Biomarkers information updated
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.
- 15 Mar 2010 Results were presented at the 59th Annual Scientific Session of the American College of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History